Search
for
Sort by
Research 301–330 of 1000+
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Brimonidine Beyond a Single Specialty: Pharmacological Profile, Dermatologic Applications, and Advances in Drug Delivery Systems
- Diversification and Specialization of Touch Receptors in Skin
- Severe Insulin Resistance in a Pediatric Patient: Key Areas to Address in the Screening
- Extra-nasal odorant receptors: molecular mechanisms and therapeutic implications
- TTNPB Promotes Human Pluripotent Stem Cell‐to‐Neural Stem Cell Transition via Modulation of Chromatin Accessibility and the S‐(5′‐adenosyl)‐L‐homocysteine/Choline Metabolic Network
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Androgenic Alopecia: Recent Understanding of the Androgenetic Receptor-Mediated Molecular Mechanisms and Current Pharmacotherapy
- Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Expanding the Scope of PROTACs: Opportunities and Challenges in Topical Delivery
- Genetic and molecular aspects of androgenetic alopecia
- Beyond acne: Current aspects of sebaceous gland biology and function
- Non-canonical dimerization of the androgen receptor and other nuclear receptors: implications for human disease
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- New developments in our understanding of acne pathogenesis and treatment
- Through the lens of hair follicle neogenesis, a new focus on mechanisms of skin regeneration after wounding
- Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician’s Choice Standard-of-Care Chemotherapy
- Dermatopathology and molecular genetics
- Go with the Flow
- PRIDE syndrome associated with panitumumab treatment – case report and literature review
- Dacomitinib-Induced Paronychia Associated With PRIDE Syndrome in a Patient With Non-Small Cell Lung Cancer
- From gene to therapy in spinal and bulbar muscular atrophy: Are we there yet?
- Emerging pharmacotherapies for Androgenetic Alopecia
- Advances in histamine-mediated allergy management: Expanding perspectives on cetirizine’s therapeutic, safety, and toxicological implications
- A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex
- NANOCARRIER-BASED DELIVERY OF MINOXIDIL: CURRENT PERSPECTIVES AND FUTURE DIRECTIONS IN ALOPECIA THERAPY
- Industry updates in advanced therapy medicinal products and regenerative medicine – March 2026
- Recent discoveries and developments of androgen receptor based therapy for prostate cancer